↓ Skip to main content

Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer

Overview of attention for article published in PLOS ONE, January 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
5 news outlets
blogs
2 blogs
twitter
7 X users
facebook
4 Facebook pages

Citations

dimensions_citation
214 Dimensions

Readers on

mendeley
179 Mendeley